Clinical Trial Update: Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Niraparib in metastatic pancreatic cancer after prior chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Pancreatic Cancer | Phase 2 | Status: UNKNOWN